Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis
Journal of Interferon & Cytokine Research · 01.11.2023 · 43 (11) · 512-517
DOI: 10.1089/jir.2023.0057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, erschienen am 01.11.2023. Verfasst von Liuqing Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jin Hua, China. Hauptthemen laut MEDLINE: Cytokines, Arthritis, Rheumatoid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a type of arthritis autoimmune disease characterized by systemic chronic inflammation. C-C Chemokine ligand 20 (CCL20) is the same as most chemokines with immunomodulatory and inflammatory processes. The correlation of CCL20 in RA remains unclear. This study aimed to explore the association among levels of CCL20, T helper cell (TH) subset (Th1/Th2/Th17)-related cytokine levels, and clinical indices of RA disease activity. Serum CCL20 levels were quantified by enzyme-linked immunosorbent assay, and a flow-fluorescence technique was used to assess Th1/Th2/Th17-related cytokine levels. The serum CCL20 levels in patients were significantly higher than those in healthy controls and positively associated with C-reactive protein levels, erythrocyte sedimentation rate, and disease activity score-28 (DAS28). Patients with RA were categorized into 4 major groups, including remission, low, moderate, and high disease activity, with related DAS28 scores for each group. CCL20 levels of the disease moderate/high activity group were moderately positively correlated with IL-6 levels, but not with the other Th1/Th2/Th17-related cytokines. Serum CCL20 levels correlate strongly with RA disease activity and clinical inflammation and were significantly elevated in patients compared to healthy individuals. CCL20 plays a key role in the immune response of patients with RA and is, therefore, a potential biomarker of disease activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jin Hua, China.
ORCID-Profile: Hongwei Du
Zitieren
APA
Wang, L., Hong, X., & Du, H. (2023). Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis. Journal of Interferon & Cytokine Research, 43(11), 512-517. https://doi.org/10.1089/jir.2023.0057
Vancouver
Wang L, Hong X, Du H. Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis. Journal of Interferon & Cytokine Research. 2023;43(11):512-517. doi:10.1089/jir.2023.0057
BibTeX
@article{Wang2023,
author = {Wang, Liuqing and Hong, Xuelian and Du, Hongwei},
title = {Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis},
journal = {Journal of Interferon & Cytokine Research},
year = {2023},
volume = {43},
number = {11},
pages = {512--517},
doi = {10.1089/jir.2023.0057}
}
EUVIMED